Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Multi Ways Holdings Limited | MWG | Mar 28, 2024 | 0.31 | -3.94 |
MultiPlan A | MPLN | Mar 28, 2024 | 0.81 | -3.86 |
MultiSensor AI | MSAI | Mar 28, 2024 | 2.26 | 0.00 |
Mural Oncology | MURA | Mar 28, 2024 | 4.89 | -1.21 |
Murano Global Investments | MRNO | Mar 28, 2024 | 12.67 | 0.00 |
Murphy Oil | MUR | Mar 28, 2024 | 45.70 | +1.31 |
Murphy USA | MUSA | Mar 28, 2024 | 419.20 | +0.51 |
Mustang Bio | MBIO | Mar 28, 2024 | 1.04 | +10.64 |
MV Oil Royalty Trust | MVO | Mar 28, 2024 | 10.69 | +0.85 |
MVB Financial | MVBF | Mar 28, 2024 | 22.31 | +2.11 |
My Size | MYSZ | Mar 28, 2024 | 0.43 | -0.84 |
Myers Industries | MYE | Mar 28, 2024 | 23.17 | -0.22 |
MyMD Pharmaceuticals | MYMD | Mar 28, 2024 | 2.39 | +1.70 |
Mynaric ADR | MYNA | Mar 28, 2024 | 4.79 | +5.38 |
Myomo | MYO | Mar 28, 2024 | 3.27 | -6.57 |
MYR Group | MYRG | Mar 28, 2024 | 176.75 | +0.86 |
Myriad Genetics | MYGN | Mar 28, 2024 | 21.32 | -0.37 |
MYT Netherlands Parent ADR | MYTE | Mar 28, 2024 | 3.18 | +0.95 |
N-able | NABL | Mar 28, 2024 | 13.07 | +0.38 |
N2OFF | NITO | Mar 28, 2024 | 1.29 | 0.00 |
NaaS Technology ADR | NAAS | Mar 28, 2024 | 1.24 | 0.00 |
Nabors Energy Transition II | NETD | Mar 28, 2024 | 10.40 | 0.00 |
Nabors Energy Transition II | NETDU | Mar 28, 2024 | 10.48 | 0.00 |
Nabors Industries | NBR | Mar 28, 2024 | 86.13 | -2.08 |
NACCO Industries | NC | Mar 28, 2024 | 30.20 | +1.00 |
Nano Dimension ADR | NNDM | Mar 28, 2024 | 2.79 | -0.54 |
Nano Labs | NA | Mar 28, 2024 | 1.68 | +4.35 |
Nano-X Imaging | NNOX | Mar 28, 2024 | 9.77 | -1.11 |
Nanobiotix ADR | NBTX | Mar 28, 2024 | 6.50 | +2.36 |
NanoVibronix | NAOV | Mar 28, 2024 | 0.90 | -3.44 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.